Literature DB >> 8409073

Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization.

K Yoshida1, K L Gould.   

Abstract

OBJECTIVES: The purpose of this study was to determine the clinical prognostic value, with and without revascularization, of the size of myocardial infarction and viability as measured by positron emission tomography (PET).
BACKGROUND: Poorly contracting but viable myocardium recovers contractile performance after revascularization. However, the quantitative relation among size of infarction and viability by PET, ejection fraction and long-term survival with and without revascularization in patients after myocardial infarction has not been previously reported.
METHODS: Infarct size and viability imaged by PET using generator-produced rubidium-82 were quantified objectively by automated software and related to coronary arteriography, left ventricular ejection fraction, revascularization and 3-year mortality.
RESULTS: Myocardial infarction or scar > or = 23% of the left ventricle was associated with a 3-year mortality rate of 43% versus that of 5% associated with scar < 23% of the left ventricle (p = 0.014). An ejection fraction < or = 43% correlated with a 3-year mortality rate of 38% compared with 6% for an ejection fraction > or = 43% (p = 0.029) because infarct size > or = 23% of the left ventricle was also associated with an ejection fraction < or = 43%. For patients with a low ejection fraction (< or = 43%) or large infarcts/scar (> or = 23% of the left ventricle), ejection fraction value or infarct size did not predict mortality. However, in patients with an ejection fraction < or = 43%, the absence of viable myocardium in arterial zones at risk was associated with a mortality rate of 63% versus 13% in subjects with viable myocardium, a difference with only a 5.9% probability of occurring by chance alone (p = 0.059). For all patients with viable myocardium in arterial zones at risk, the mortality rate was 8%, and 80% had revascularization over 3 years. For patients with only fixed scar in arterial zones at risk, the mortality rate was 50% versus 8% (p = 0.018), and 40% had revascularization, with no difference in mortality with or without revascularization, thereby suggesting no benefit in this subgroup.
CONCLUSIONS: Size of scar and viable myocardium by PET in arterial zones at risk in patients after myocardial infarction are highly predictive of 3-year mortality, particularly in patients with low ejection fraction, and identify patients who are suitable candidates for revascularization after myocardial infarction.

Entities:  

Mesh:

Year:  1993        PMID: 8409073     DOI: 10.1016/0735-1097(93)90407-r

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

1.  The challenge of quantifying defect size and severity: reality versus algorithm.

Authors:  R L Eisner; R E Patterson
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

Review 2.  Non-transplant surgery for heart failure.

Authors:  S Westaby
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

Review 3.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

4.  Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: A meta-analysis.

Authors:  Yoichi Inaba; Jennifer A Chen; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2010-04-09       Impact factor: 5.952

5.  Assessment of Regional Viability in the Infarct Zone Following Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 6.  Clinical assessment of myocardial hibernation.

Authors:  Arend F L Schinkel; Jeroen J Bax; Don Poldermans
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

7.  The utility of 82Rb PET for myocardial viability assessment: Comparison with perfusion-metabolism 82Rb-18F-FDG PET.

Authors:  Jonathan B Moody; Keri M Hiller; Benjamin C Lee; Alexis Poitrasson-Rivière; James R Corbett; Richard L Weinberg; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-02-26       Impact factor: 5.952

Review 8.  The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations.

Authors:  Timm Dickfeld; Christopher Kocher
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

9.  Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.

Authors:  M F Di Carli; F Asgarzadie; H R Schelbert; R C Brunken; S Rokhsar; J Maddahi
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

10.  Application of nuclear cardiology in the coronary care unit: achievements and challenges.

Authors:  P K Shah
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.